Open AccessS3129 Establishing Upper GI Toxicity Remission With Vedolizumab Maintenance Therapy While Resuming Immune Checkpoint Inhibitor
Author(s) -
Antony Mathew,
Yinghong Wang
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000786048.07923.f8
Subject(s) - medicine , vedolizumab , pembrolizumab , nausea , adverse effect , vomiting , gastroenterology , maintenance therapy , ipilimumab , surgery , cancer , chemotherapy , inflammatory bowel disease , immunotherapy , disease